Combined Use of Growth Hormone and Gonadotropin-releasing Hormone Analogues in Precocious Puberty: Theoretic and Practical Considerations-Reference-Cited by-同舟云学术

Combined Use of Growth Hormone and Gonadotropin-releasing Hormone Analogues in Precocious Puberty: Theoretic and Practical Considerations

Published:1999-10-01 Issue:Supplement_5 Volume:104 Page:1010-1014
ISSN:1098-4275
Container-title:Pediatrics
language:en
Short-container-title:

Author:

Walvoord Emily C.¹,Pescovitz Ora Hirsch¹

Affiliation:

1. 1From the Department of Pediatrics, Section of Pediatric Endocrinology and Diabetology, Indiana University, James Whitcomb Riley Hospital for Children, Indianapolis, Indiana.

Abstract

The rationale underlying the use of gonadotropin-releasing hormone analogues (GnRHa) to treat patients with central precocious puberty is reviewed. GnRHa are now considered the treatment of choice for patients with central precocious puberty, but the adult heights that these patients attain often fall short of what would be expected according to their genetic potential. This has led to investigations of whether adding growth hormone to GnRHa therapy can improve adult height. The results of recent combination trials are presented and analyzed.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Link

https://publications.aap.org/pediatrics/article-pdf/104/Supplement_5/1010/823047/1010.pdf

Reference38 articles.

1. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.;Bertelloni;Eur J Pediatr.,1998

2. Precocious puberty.;Shankar;Adv Endocrinol Metab.,1995

3. Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty.;Kletter;J Clin Endocrinol Metab.,1994

4. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue: a comparative study with re-evaluation of predictions by the Bayley-Pinneau method.;Kauli;Horm Res.,1997

5. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist.;Oostdijk;Arch Dis Child.,1996

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, Treatment, and Outcomes of Males with Central Precocious Puberty;Endocrinology and Metabolism Clinics of North America;2024-06

2. Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls;Frontiers in Endocrinology;2022-12-14

3. Long-Term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls;The Journal of Clinical Endocrinology & Metabolism;2019-11-08

4. Primary and Secondary Amenorrhea and Precocious Puberty;Comprehensive Gynecology;2013

5. Factors Affecting Growth Velocity during Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Idiopathic Central Precocious Puberty;Annals of Pediatric Endocrinology & Metabolism;2012